Tacrolimus and posttransplant diabetes mellitus in renal transplantation

Transplantation. 2005 Jun 15;79(11):1465-9. doi: 10.1097/01.tp.0000157870.21957.e5.

Abstract

The most prominent side effect of tacrolimus is the induction of posttransplant diabetes mellitus (PTDM). In this review, the authors discuss the incidence, mechanism, prevention, and treatment of tacrolimus-induced PTDM in renal patients.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 2 / chemically induced*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / immunology
  • Postoperative Complications / chemically induced*
  • Risk Factors
  • Tacrolimus / antagonists & inhibitors*

Substances

  • Immunosuppressive Agents
  • Tacrolimus